**Specifications table**TableSubject areaBiologyMore specific subject areaTranscriptomicsType of dataTable, text file.How data was acquiredmRNA data from RNA-Sequencing (RNA-Seq) technology and bioinformatic analysis were used to identify a molecular signature and pathways affected by BaP exposure.Data formatFiltered and analyzed.Experimental factorsAnalysis of gene expression profile RNA-Seq data from a BaP experimentExperimental featuresRNA-Seq reads were trimmed and the clean reads analyzed.Gene read mapping, differential expression analysis (DE) and GSEA and SNEA were performed from tilapia liver and testis tissue after BaP-treatment.Quantitative PCR (qPCR) was used to evaluate the transcriptomic changes observed in BaP-exposed male tilapia.Data source locationSample source and tissue harvest were located at Cinvestav-Merida, Yucatan, Mexico. The BaP experiment was carried out at Cinvestav-Merida. Sample analysis was performed at Cinvestav-Merida and the University of Florida (Gainesville, FL, USA).Data accessibilityTranscriptomic data are presented in this article. All RNA-Seq data were submitted to NCBI׳s Gene Expression Omnibus (GEO) and can be accessed via <https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116687>(accession number GSE116687).Related research article[@bib1] COLLI-DULA, R. C. et al. Transcriptome Analysis Reveals Novel Insights Into the Response of Low-dose Benzo(a)pyrene Exposure in Male Tilapia. **Aquatic Toxicology**, v. 201, n. 15, pp. 162--173, Aug 2018. ISSN 0166-445×.

**Value of data**•The data explores the biological mechanism of action of BaP in the liver and testis of male tilapia by a high throughput transcriptomic approach (RNA-Sequencing).•The data provides ample information of changes in gene expression, subnetworks and functional enrichment analysis associated with several biological processes after BaP treatment.•The molecular signature identified for BaP exposure is very useful to other researchers that may explore the mechanism of action of BaP in non-model organism such as tilapia.•New gene sets associated with molecular adverse effects of BaP can be useful in understanding the role of BaP into the activation of apoptotic signals in tilapia.•This data may contribute to understanding the BaP mechanisms associated with adverse effects in tilapia.

1. Data {#s0005}
=======

These data sets provide information on the BaP molecular effects in tilapia testes and liver. [Table 1](#t0005){ref-type="table"} presents all the primer sets used for qPCR analysis. All primers used were previously validated as indicated in the 2^−ΔΔCT^ method [@bib2]. Of these genes evaluated, *Cyp1b1*, *Ddit4, Gadd45b* and *Fasn* showed significant changes in their levels of expression from BaP exposure (*p *\< 0.05) (Table 5 in [@bib1]). [Table 2](#t0010){ref-type="table"} presents a partial list of the characterization of gene expression profiling of RNA-data by BaP exposure. This data shows a larger number of altered genes in the liver related with adverse molecular effects on the cell cycle and with several other biological processes. [Table 3](#t0015){ref-type="table"} shows GO categories and [Table 4](#t0020){ref-type="table"} identifies gene networks altered by a low concentration of BaP in the liver and testis of male tilapia. All significantly altered genes are listed in [Table SI](#s0030){ref-type="sec"} as well as identified GO categories and subnetworks which are present.Table 1Sequences of primers used in the qRT-PCR analysis.Table 1**Gene symbolsDescriptionForward primer 5′→3′Reverse primer 5′→3′Amplicon size (bp)Aligned temp (°C)**CYP1B1Cytochrome P450, family 1, subfamily B, polypeptide 1gggctacaccgtaccaaagaagcgctctgggtcaaagata10456GADD45Growth arrest and DNA damage inducible betaggagacggtgagtcaagctcgcggactcgtagactccaac8458DDIT4DNA-damage-inducible transcript 4tctcattgacctctgcgttgaccagagcgagctgaaatgt9958IGF2Insulin-like growth factor 2gcccttccctttgacattatgcgccttgtccttgttttag9258TET3Tet methylcytosine dioxygenase 3aaaggacccttgtgtcatgcgtttgcttttcaggcagtcc8058FASNFatty acid synthasegagacggactgccttacagcgctgcagtctgtggatcaaa7958RPL8Ribosomal Protein L8gttgctggaggtggacgtatggatgctcaacagggttcat12556Table 2Partial list of the characterization of gene expression profiling of RNA-data. Identified transcripts are involved with electron transport/ATP synthesis, DNA methylation, growth and development, cell cycle machinery and apoptotic signals.Table 2**Characterization of gene expression profiling of tilapia RNA-seq dataLiverTestisHGNC symbolDescriptionFold change*p*-valueFold change*p*-valueElectron transport/ATP synthesis**ACLYATP citrate lyase a \[Source:ZFIN;Acc:ZDB-GENE-031113-1\]−5.56.35E−07−1.0NSATP6V1E1AATPase, H+ transporting, lysosomal, V1 subunit E1a \[Source:ZFIN;Acc:ZDB-GENE-041212-51\]3.82.6E−06NSATAD2ATPase family, AAA domain containing 2 \[Source:HGNC Symbol;Acc:HGNC:30123\]−4.12.2E−031.1NSATAD2ATPase family, AAA domain containing 2 \[Source:ZFIN;Acc:ZDB-GENE-030131-7003\]−2.11.2E−021.0NSPSMD1proteasome 26S subunit, non-ATPase 1 \[Source:ZFIN;Acc:ZDB-GENE-040426-810\]−1.62.1E−021.0NSABCE1ATP-binding cassette, sub-family E (OABP), member 1 \[Source:ZFIN;Acc:ZDB-GENE-040426-1995\]1.82.5E−02−1.1NSABCA3ATP-binding cassette, sub-family A (ABC1), member 3b \[Source:ZFIN;Acc:ZDB-GENE-050517-2\]−1.72.6E−02−1.1NSCFTRcystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) \[Source:ZFIN;Acc:ZDB-GENE-050517-20\]2.23.1E−02−1.0NSLIG1ligase I, DNA, ATP-dependent \[Source:ZFIN;Acc:ZDB-GENE-110404-2\]2.03.7E−021.1NSNKAIN1Na+/K+ transporting ATPase interacting 1 \[Source:ZFIN;Acc:ZDB-GENE-040426-1472\]2.14.1E−02−1.3NSTAP2ATP-binding cassette, sub-family B (MDR/TAP), member 3 like 1 \[Source:ZFIN;Acc:ZDB-GENE-030616-245\]−2.94.5E−021.4NSAGTPBP1ATP/GTP binding protein 1 \[Source:ZFIN;Acc:ZDB-GENE-081104-267\]−1.74.6E−02−1.0NSOPLAH5-oxoprolinase (ATP-hydrolysing) \[Source:ZFIN;Acc:ZDB-GENE-121214-293\]1.64.6E−021.0NSATP6V1C1ATPase, H+ transporting, lysosomal, V1 subunit C1b \[Source:ZFIN;Acc:ZDB-GENE-041010-104\]−1.63.1E−02−1.2NSATP5IATP synthase, H+ transporting, mitochondrial Fo complex, subunit Ea \[Source:ZFIN;Acc:ZDB-GENE-070928-12\]−21.6E−02−1.2NSATP7AATPase, Cu++ transporting, alpha polypeptide \[Source:ZFIN;Acc:ZDB-GENE-060825-45\]−2.21.8E−03−1.1NS***Solute carrier families***SLC22A7solute carrier family 22 member 7 \[Source:HGNC Symbol;Acc:HGNC:10971\]5.62.0E−04−38.95.0E−03SLC22A7solute carrier family 22 member 7 \[Source:HGNC Symbol;Acc:HGNC:10971\]5.62.2E−04−38.94.83E−03SLC13A1solute carrier family 13 (sodium/sulphate symporters), member 1 \[Source:ZFIN;Acc:ZDB-GENE-031222-3\]5.44.2E−02−1.3NSSLC34A2solute carrier family 34 (type II sodium/phosphate cotransporter), member 2b \[Source:ZFIN;Acc:ZDB-GENE-030709-1\]4.62.6E−021.2NSSLCO2A1solute carrier organic anion transporter family, member 2A1 \[Source:ZFIN;Acc:ZDB-GENE-060606-3\]2.41.5E−031.2NS**DNA methylation**METTL21Amethyltransferase like 21A \[Source:ZFIN;Acc:ZDB-GENE-050320-145\]4.42.0E−02−1.3NSHNMThistamine N-methyltransferase \[Source:HGNC Symbol;Acc:HGNC:5028\]3.12.4E−031.2NSHMGCS13-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) \[Source:ZFIN;Acc:ZDB-GENE-040426-1042\]2.81.0E−021.1NSTRMT11tRNA methyltransferase 11 homolog (S. cerevisiae) \[Source:ZFIN;Acc:ZDB-GENE-040426-953\]2.62.8E−02−1NSMETTL18methyltransferase like 18 \[Source:HGNC Symbol;Acc:HGNC:28793\]2.61.3E−02−1.2NSTET3tet methylcytosine dioxygenase 3 \[Source:ZFIN;Acc:ZDB-GENE-060526-109\]−2.11.6E−02−1.2NSMETTL5methyltransferase like 5 \[Source:ZFIN;Acc:ZDB-GENE-041010-21\]−2.47.4E−031NSDPY30dpy-30 histone methyltransferase complex regulatory subunit \[Source:ZFIN;Acc:ZDB-GENE-040718-136\]−2.52.1E−03−1.1NSTRMT44tRNA methyltransferase 44 homolog (S. cerevisiae) \[Source:ZFIN;Acc:ZDB-GENE-041010-189\]−38.2E−03−1.2NS**Growth and development**IGFBP3insulin-like growth factor binding protein 3 \[Source:ZFIN;Acc:ZDB-GENE-040412-1\]4.91.9E--02--1.4NSRXFP4relaxin/insulin like family peptide receptor 4 \[Source:HGNC Symbol;Acc:HGNC:14666\]2.73.1E--02----IGF2insulin-like growth factor 2 \[Source:RefSeq peptide;Acc:NP_001266572\]2.51.8E--021.1NSIGFBP7insulin-like growth factor binding protein 7 \[Source:ZFIN;Acc:ZDB-GENE-040426-2423\]1.83.0E--021NSIGF2Rinsulin-like growth factor 2 receptor \[Source:ZFIN;Acc:ZDB-GENE-041014-300\]--1.82.7E--02--1.1NSTHRBthyroid hormone receptor beta \[Source:ZFIN;Acc:ZDB-GENE-990415-268\]--22.5E--03----THRSPthyroid hormone responsive \[Source:ZFIN;Acc:ZDB-GENE-081022-19\]--4.81.3E--03----**Cell cycle machinery**CADM1cell adhesion molecule 1a \[Source:ZFIN;Acc:ZDB-GENE-080505-2\]8.21.3E--04--1.3NSCEP152centrosomal protein 152 \[Source:ZFIN;Acc:ZDB-GENE-111005-1\]4.84.2E−041.2NSCEP57centrosomal protein 57 \[Source:HGNC Symbol;Acc:HGNC:30794\]2.92.6E−031.1NSCEP135centrosomal protein 135 \[Source:ZFIN;Acc:ZDB-GENE-041210-325\]2.33.4E−02−1.1NSTACSTD2epithelial cell adhesion molecule \[Source:ZFIN;Acc:ZDB-GENE-040426-2209\]2.31.0E−031.2NSNCAM1neural cell adhesion molecule 1a \[Source:ZFIN;Acc:ZDB-GENE-990415-31\]−2.44.2E−02−1.5NSCEBPWcentromere protein W \[Source:ZFIN;Acc:ZDB-GENE-100922-200\]−3.94.4E−021.1NSCHL1cell adhesion molecule L1-like b \[Source:ZFIN;Acc:ZDB-GENE-091105-1\]−4.31.4E−031.1NSCENPFcentromere protein F \[Source:ZFIN;Acc:ZDB-GENE-041111-205\]−5.67.0E−041.3NSNDC80NDC80 kinetochore complex component \[Source:ZFIN;Acc:ZDB-GENE-030131-904\]−5.93.0E−03−1.0NSGOS2G0/G1 Switch 2, Putative Lymphocyte G0/G1 Switch Gene−8.27.5E−11−43.41.6E−14***Cyclin***CDKL5cyclin dependent kinase like 5 \[Source:HGNC Symbol;Acc:HGNC:11411\]2.68.0E−031.20NSCCNG1cyclin G1 \[Source:ZFIN;Acc:ZDB-GENE-020322-1\]2.23.8E−03−1.00NSNUCKS1nuclear casein kinase and cyclin-dependent kinase substrate 1a \[Source:ZFIN;Acc:ZDB-GENE-040912-175\]2.09.9E−031.16NSMRRFmitochondrial ribosome recycling factor \[Source:ZFIN;Acc:ZDB-GENE-040704-12\]2.02.4E−02−1.25NSCDK6cyclin-dependent kinase 6 \[Source:ZFIN;Acc:ZDB-GENE-060503-786\]1.92.0E−021.17NSCCNIcyclin I \[Source:ZFIN;Acc:ZDB-GENE-040426-2898\]1.73.0E−02−1.15NSCCNT2cyclin T2b \[Source:ZFIN;Acc:ZDB-GENE-030131-183\]−1.64.1E−021.01NSCCNG2cyclin G2 \[Source:ZFIN;Acc:ZDB-GENE-021016-1\]−2.11.6E−02−1.28NSCCNB2cyclin B2 \[Source:ZFIN;Acc:ZDB-GENE-030429-12\]−2.11.3E−02−1.07NSCNNM1cyclin and CBS domain divalent metal cation transport mediator 1 \[Source:HGNC Symbol;Acc:HGNC:102\]−2.29.8E−031.05NSCDK1cyclin-dependent kinase 1 \[Source:ZFIN;Acc:ZDB-GENE-010320-1\]−3.29.3E−03−1.16NSCCNB3cyclin B3 \[Source:ZFIN;Acc:ZDB-GENE-060929-684\]−12.94.5E−04−1.04NS***Mitotic spindle dynamics***MZT2Bmitotic spindle organizing protein 2B \[Source:ZFIN;Acc:ZDB-GENE-040801-87\]2.33.4E−02−1.2NSCDK2cyclin-dependent kinase 2 \[Source:ZFIN;Acc:ZDB-GENE-040426-2741\]−2.44.8E−021.11NSNUSAP1nucleolar and spindle associated protein 1 \[Source:ZFIN;Acc:ZDB-GENE-030827-5\]−3.53.4E−03−1.1NSBUB1BUB1 mitotic checkpoint serine/threonine kinase \[Source:ZFIN;Acc:ZDB-GENE-081104-75\]−4.56.1E−03−1.0NSPLK1polo-like kinase 1 (Drosophila) \[Source:ZFIN;Acc:ZDB-GENE-021115-7\]−8.13.8E−04−1.0NS**Apoptotic signals**VWA11von Willebrand factor A domain containing 11 \[Source:ZFIN;Acc:ZDB-GENE-141211-58\]44.31.01E−0851.4E−02ID4inhibitor of DNA binding 4 \[Source:ZFIN;Acc:ZDB-GENE-051113-208\]2.21.2E−03−2.2NSTBRG4transforming growth factor beta regulator 4 \[Source:ZFIN;Acc:ZDB-GENE-091020-8\]1.94.4E−021.2NSTIGARtp53-induced glycolysis and apoptosis regulator a \[Source:ZFIN;Acc:ZDB-GENE-060312-25\]1.63.2E−02−1.4NSTIGARtp53-induced glycolysis and apoptosis regulator a \[Source:ZFIN;Acc:ZDB-GENE-060312-25\]1.63.2E−02−1.4NSRABGAP1RAB GTPase activating protein 1 \[Source:HGNC Symbol;Acc:HGNC:17155\]−1.72.9E−02−1.1NSRAB6CRAB6A, member RAS oncogene family \[Source:ZFIN;Acc:ZDB-GENE-040426-2849\]−1.81.7E−021.1NSRAB4B-EGLN2RAB4B, member RAS oncogene family \[Source:HGNC Symbol;Acc:HGNC:9782\]−2.44.2E−021.4NSDDIT3DNA-damage-inducible transcript 3 \[Source:ZFIN;Acc:ZDB-GENE-070410-90\]−2.49.7E−03−1.1NSRASGEF1BRasGEF domain family member 1B \[Source:HGNC Symbol;Acc:HGNC:24881\]−3.21.9E−03−2.2NSRASL11ARAS-like, family 11, member A \[Source:ZFIN;Acc:ZDB-GENE-050417-384\]-4.52.0E−04−1.5NSRAB29RAB29, member RAS oncogene family \[Source:HGNC Symbol;Acc:HGNC:9789\]−5.15.0E−03−1.1NSDDIT4LDNA damage inducible transcript 4 like \[Source:HGNC Symbol;Acc:HGNC:30555\]−9.32.0E−04−1.2NS**Others**KRT4keratin 4 \[Source:ZFIN;Acc:ZDB-GENE-000607-83\]7.12.10E−0261.79E−02ASTLsix-cysteine containing astacin protease 1 \[Source:ZFIN;Acc:ZDB-GENE-070621-1\]6.18.30E−084.73.61E−04RN7SKP275RN7SKP275 (RNA, 7SK Small Nuclear Pseudogene 275) is a Pseudogene6.11.30E−02−2.32.78E−02BPIFCBPI Fold Containing Family C4.61.00E−023.54.06E−02ITI1Hinter-alpha-trypsin inhibitor heavy chain 1 \[Source:ZFIN;Acc:ZDB-GENE-130530-650\]47.20E−0623.16E−02PENKproenkephalin a \[Source:ZFIN;Acc:ZDB-GENE-030729-31\]3.12.20E−02−4.42.81E−02PGLYRP2peptidoglycan recognition protein 2 \[Source:HGNC Symbol;Acc:HGNC:30013\]2.81.60E−034.61.74E−02DIO2Iodothyronine Deiodinase 22.80.0031.2NSLECT2leukocyte cell derived chemotaxin 2 \[Source:HGNC Symbol;Acc:HGNC:6550\]2.57.00E−0416.62.20E−06APOA1apolipoprotein A-Ia \[Source:ZFIN;Acc:ZDB-GENE-990415-14\]1.73.40E−024.74.18E−03APOHapolipoprotein H \[Source:HGNC Symbol;Acc:HGNC:616\]1.72.80E−023.31.53E−02NCOA7Nuclear Receptor Coactivator 7−10.24.60E−15−2.74.00E−02Table 3Representative list of GO terms significantly affected in the liver and testis of male tilapia exposed to BaP. Determined by Gene Set Enrichment Analysis (GSEA; *p \< 0.05*, fold change ≥ 10%).Table 3**TissueGene set categoryNameMedian fold change*p*-valueLiverBiological process**mitosis−2.81.9E−04cell cycle−2.52.7E−04triglyceride biosynthetic process−3.07.9E−04long-chain fatty-acyl-CoA biosynthetic process−3.28.2E−04mitotic cytokinesis−6.61.1E−03cell-cell signaling2.91.1E−03G2-M transition of mitotic cell cycle−2.41.3E−03cytokinesis−5.81.7E−03cellular response to calcium ion−3.32.5E−03cellular response to organic substance−3.93.3E−03synaptic transmission−2.04.5E−03peptidyl-serine phosphorylation−2.64.7E−03mitotic cell cycle−2.47.3E−03activation of MAPK activity−2.17.7E−03cell division−2.41.1E−02lipid homeostasis−5.01.3E−02exocytosis−3.41.4E−02mitotic spindle assembly checkpoint−4.51.5E−02response to ethanol−2.31.8E−02cellular response to glucose stimulus−2.02.0E−02negative regulation of signal transduction2.12.0E−02DNA metabolic process−4.22.0E−02fatty acid biosynthetic process−2.72.1E−02microtubule-based movement−3.22.4E−02cytokine-mediated signaling pathway−2.22.4E−02epidermis development2.12.4E−02positive regulation of MAPK cascade2.52.5E−02sterol biosynthetic process3.12.5E−02cellular lipid metabolic process−2.52.7E−02positive regulation of JUN kinase activity−3.93.0E−02apoptotic process−2.13.1E−02cell surface receptor signaling pathway1.83.2E−02response to testosterone−2.53.2E−02lipid catabolic process−3.23.2E−02actin cytoskeleton reorganization−2.23.3E−02meiotic nuclear division−3.43.9E−02positive regulation of gene expression−2.13.9E−02immune system process−1.74.4E−02biosynthetic process2.94.6E−02**Cellular component**spindle pole−5.24.4E−05chromosome, centromeric region−3.51.8E−04kinetochore−4.53.5E−04proteinaceous extracellular matrix−2.11.8E−03condensed chromosome kinetochore−4.52.1E−03spindle−2.82.8E−03chromosome−2.43.3E−03spindle microtubule−3.54.3E−03external side of plasma membrane−1.94.5E−03extracellular region−1.69.1E−03anchored component of membrane−2.61.8E−02axon−2.42.6E−02cell-cell junction−1.72.7E−02cytoskeleton−2.12.8E−02kinesin complex−4.62.9E−02microtubule−2.42.9E−02cell−2.23.3E−02microtubule organizing center−2.04.0E−02**Molecular function**iron ion binding−2.31.1E−03protein C-terminus binding−2.71.1E−03microtubule binding−2.73.2E−03heme binding−1.94.2E−03protein heterodimerization activity−2.45.8E−03protein serine-threonine kinase activity−2.17.7E−03hormone activity2.59.0E−03oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen2.59.6E−03growth factor activity2.51.2E−02drug binding−3.31.2E−02metallopeptidase activity−1.91.6E−02microtubule motor activity−3.21.8E−02protein homodimerization activity−2.22.8E−02calmodulin binding−2.44.3E−02structural constituent of cytoskeleton−2.74.7E−02carbohydrate binding−2.04.8E−02sequence-specific DNA binding RNA polymerase II transcription factor activity−2.44.9E−02**TestisBiological process**regulation of proteolysis9.39.4E−06proteolysis10.07.1E−05leukotriene biosynthetic process15.55.1E−04negative regulation of endopeptidase activity9.39.6E−04hemostasis10.32.3E−03oxygen transport−7.55.9E−03protein heterooligomerization−7.55.9E−03wound healing7.57.3E−03fibrinolysis6.01.6E−02cobalamin metabolic process11.11.8E−02cellular protein metabolic process8.63.0E−02response to calcium ion5.53.7E−02inflammatory response3.64.1E−02response to peptide hormone9.34.4E−02response to cytokine9.34.8E−02**Cellular component**extracellular space5.02.7E−06extracellular region3.36.7E−05keratin filament6.01.8E−04intermediate filament6.03.7E−04hemoglobin complex−7.54.1E−04Golgi lumen−4.21.5E−03anchored component of external side of plasma membrane15.55.6E−03secretory granule8.62.7E−02platelet alpha granule9.33.1E−02Table 4Partial list of subnetworks significantly affected in the liver and testis of male tilapia exposed to BaP (*p *\<* *0.05, fold change ≥ 10%).Table 4**TissueGene set seedMedian fold change*p*-valueLiver**kinetochore assembly−3.22.5E−04telophase−3.85.4E−04microtubule cytoskeleton assembly−2.28.3E−04anaphase−3.19.7E−04mitotic spindle positioning−3.21.4E−03meiosis−2.22.1E−03mitotic nuclear membrane assembly/disassembly−3.22.3E−03microtubule/kinetochore interaction−5.62.6E−03mitotic checkpoint−3.23.0E−03mitotic spindle checkpoint−3.23.2E−03nuclear division−3.24.7E−03mitotic spindle assembly−4.28.3E−03meiosis II−4.58.8E−03fatty acid oxidation−2.39.1E−03nuclear fragmentation−2.39.7E−03sister chromatid cohesion−3.21.0E−02chromosome condensation−2.41.1E−02mitotic spindle orientation2.41.1E−02spindle assembly−2.71.4E−02Schwann cell migration−3.21.5E−02DNA replication during S phase−3.91.7E−02mitotic prometaphase−3.21.7E−02mesenchymal stem cell differentiation−1.91.8E−02synapse maturation−2.42.0E−02monocyte differentiation−2.52.0E−02mitotic sister chromatid segregation−3.22.6E−02mitotic metaphase plate congression−3.22.7E−02chromosome segregation−2.82.8E−02regulation of action potential1.72.9E−02adipogenesis−2.23.0E−02nerve sprouting−2.43.0E−02interphase−2.43.0E−02microtubule bundling−2.83.1E−02cellular extravasation−3.13.1E−02lipid oxidation−3.03.5E−02blood-retinal barrier−2.03.7E−02Glycogen degradation−2.23.8E−02**Testis**blood clotting5.55.2E−04neutrophil chemotaxis5.57.3E−04fibrinolysis5.69.1E−04blood vessel permeability3.71.2E−03myoblast proliferation7.51.4E−03muscle fiber development5.84.4E−03blood clot lysis5.85.6E−03T-cell homeostasis−2.35.7E−03neutrophil recruitment3.67.6E−03degranulation3.97.9E−03fibroblast proliferation3.38.2E−03neutrophil adhesion3.18.7E−03autolysis7.51.1E−02zymogen activation5.61.1E−02complement activation5.01.2E−02hemolysis3.01.5E−02chondrocyte proliferation2.91.6E−02neutrophil extravasation5.61.9E−02skin changes7.51.9E−02blood coagulation, intrinsic pathway5.82.0E−02cellular extravasation3.62.1E−02hepatic regeneration3.72.3E−02myoblast fusion3.22.3E−02neutrophil migration3.32.7E−02bacterial load4.72.8E−02antigen expression4.53.1E−02positive chemotaxis3.63.2E−02superoxide anion generation3.33.3E−02neutrophil activation3.63.4E−02immune cell chemotaxis3.63.5E−02hepatocyte apoptosis5.83.7E−02dendritic cell differentiation3.33.8E−02tissue invasion5.03.8E−02muscle fiber contraction3.03.9E−02myoblast differentiation5.84.3E−02epidermal cell differentiation6.04.4E−02innate immune response3.34.4E−02leukocyte recruitment3.14.7E−02

2. Experimental design, materials and methods {#s0010}
=============================================

Liver and testis samples were collected as were controls. Analysis of gene expression profile RNA-Seq was performed as is mentioned in [@bib1]. Briefly, Tilapia RNA-Seq reads were trimmed, clean reads aligned to reference genome using Tophat [@bib3], [@bib4]. Differential expression analysis was conducted using exact test with R package EdgeR (*p *\< 0.05; fold change \> ± 1.5 were considered as significant). Elsevier PathwayStudio^TM^ V9 (Elsevier, Inc., Rockville, MD, USA) operating with the ResNet 10.0 database was used to identify the biological mechanism that underlie the BaP effects. The gene set enrichment analysis (GSEA) and subnetwork enrichment analysis (SNEA) algorithms (applying the Mann−Whitney test with an alpha level of *p *\<* *0.05) [@bib5], [@bib6], [@bib7]. Quantitative PCR (qPCR) was used to evaluate the transcriptomic changes of key genes such as *Ddit4*, *Gadd45b* and *Igf2*, *Tet3* and *Fasn* involved in important functions, i.e, DNA damage, growth and development. The *rpl8* gene was used as the internal reference normalizer gene.
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